Skip to content
Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
Keyword
Name
Filter your search:
All
Services & Industries
Experience
Insights
News
Others
Filter your search:
Search All
Services
Experience
Insights
Professionals
Services
Industries
Insights
Trending Topics
About
Locations
Careers
Search
Close
Menu
Close
Published Articles
October 16, 2018
Lower Drug Prices Aren't Worth Higher Health Risks
Email
Facebook
LinkedIn
Twitter
Authors:
Libby Baney Burstein
Libby Baney
co-authored an article for
Drug Topics
about the risks of lower cost medicines. The article explained how making medications more affordable could also sacrifice patient safety.
Full Article
Meet the Authors
Libby Baney Burstein
Partner
Washington, D.C.
+1 202 312 7438
libby.burstein@faegredrinker.com
Related Legal Services
Health Care
Related Policy, Advocacy, and Consulting Services
Health Care & Life Sciences Consulting
Related Industries
Health & Life Sciences
Digital Health
Lower Drug Prices Aren't Worth Higher Health Risks | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=4f256b3cf62c45bc84c5202f0c3ae2dc&hash=F0486198117E45BE38AF1085AD2F65C2
Lower Drug Prices Aren't Worth Higher Health Risks | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=4f256b3cf62c45bc84c5202f0c3ae2dc&hash=F0486198117E45BE38AF1085AD2F65C2